Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus

Aims. Glucagon-like peptide-1 (GLP-1) analog promotes insulin secretion by acting on pancreatic β-cells. This antihyperglycemic treatment for type 2 diabetes mellitus (DM) has attracted increased clinical attention not only for its antihyperglycemic action but also for its potential extrapancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinnouchi, Hideaki, Sugiyama, Seigo, Yoshida, Akira, Hieshima, Kunio, Kurinami, Noboru, Suzuki, Tomoko, Miyamoto, Fumio, Kajiwara, Keizo, Matsui, Kunihiko, Jinnouchi, Tomio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398938/
https://www.ncbi.nlm.nih.gov/pubmed/25922845
http://dx.doi.org/10.1155/2015/706416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398938/
https://www.ncbi.nlm.nih.gov/pubmed/25922845
http://dx.doi.org/10.1155/2015/706416

Ejemplares similares